CRL
Income statement / Annual
Last year (2024), Charles River Laboratories International, Inc.'s total revenue was $4.05 B,
a decrease of 1.92% from the previous year.
In 2024, Charles River Laboratories International, Inc.'s net income was $10.30 M.
See Charles River Laboratories International, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/28/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$4.05 B |
$4.13 B |
$3.98 B |
$3.54 B |
$2.92 B |
$2.62 B |
$2.27 B |
$1.86 B |
$1.68 B |
$1.36 B |
| Cost of Revenue |
$2.72 B
|
$2.63 B
|
$2.51 B
|
$2.21 B
|
$1.85 B
|
$1.66 B
|
$1.43 B
|
$1.16 B
|
$1.04 B
|
$832.21 M
|
| Gross Profit |
$1.33 B
|
$1.50 B
|
$1.46 B
|
$1.33 B
|
$1.07 B
|
$958.31 M
|
$840.07 M
|
$700.92 M
|
$643.96 M
|
$531.09 M
|
| Gross Profit Ratio |
0.33
|
0.36
|
0.37
|
0.38
|
0.37
|
0.37
|
0.37
|
0.38
|
0.38
|
0.39
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$751.00 M
|
$747.86 M
|
$665.10 M
|
$619.92 M
|
$528.94 M
|
$517.62 M
|
$443.85 M
|
$371.27 M
|
$364.71 M
|
$300.41 M
|
| Other Expenses |
$353.47 M
|
$137.44 M
|
$146.58 M
|
$124.86 M
|
$111.88 M
|
$89.54 M
|
$64.83 M
|
$41.37 M
|
$41.70 M
|
$24.23 M
|
| Operating Expenses |
$1.10 B
|
$885.30 M
|
$811.68 M
|
$744.78 M
|
$640.81 M
|
$607.16 M
|
$508.68 M
|
$412.64 M
|
$406.41 M
|
$324.64 M
|
| Cost And Expenses |
$3.82 B
|
$3.51 B
|
$3.33 B
|
$2.95 B
|
$2.49 B
|
$2.27 B
|
$1.93 B
|
$1.57 B
|
$1.44 B
|
$1.16 B
|
| Interest Income |
$8.58 M
|
$5.20 M
|
$780.00 K
|
$652.00 K
|
$834.00 K
|
$1.52 M
|
$812.00 K
|
$690.00 K
|
$1.31 M
|
$1.04 M
|
| Interest Expense |
$126.29 M
|
$136.71 M
|
$59.29 M
|
$73.91 M
|
$86.43 M
|
$60.88 M
|
$63.77 M
|
$29.78 M
|
$27.71 M
|
$15.07 M
|
| Depreciation & Amortization |
$361.74 M
|
$314.12 M
|
$303.87 M
|
$265.54 M
|
$234.92 M
|
$198.10 M
|
$161.78 M
|
$131.16 M
|
$126.66 M
|
$94.88 M
|
| EBITDA |
$581.14 M |
$1.03 B |
$986.15 M |
$820.16 M |
$768.47 M |
$563.06 M |
$507.23 M |
$457.89 M |
$377.29 M |
$305.38 M |
| EBITDA Ratio |
0.14
|
0.25
|
0.25
|
0.23
|
0.26
|
0.21
|
0.22
|
0.25
|
0.22
|
0.22
|
| Operating Income Ratio |
0.06
|
0.15
|
0.16
|
0.17
|
0.15
|
0.13
|
0.15
|
0.16
|
0.14
|
0.15
|
| Total Other Income/Expenses Net |
-$134.23 M
|
-$35.98 M
|
-$27.99 M
|
-$109.15 M
|
$14.39 M
|
-$47.07 M
|
-$49.70 M
|
$8.67 M
|
-$14.63 M
|
-$11.02 M
|
| Income Before Tax |
$93.11 M
|
$581.28 M
|
$622.99 M
|
$480.71 M
|
$447.11 M
|
$304.08 M
|
$281.68 M
|
$296.96 M
|
$222.92 M
|
$195.43 M
|
| Income Before Tax Ratio |
0.02
|
0.14
|
0.16
|
0.14
|
0.15
|
0.12
|
0.12
|
0.16
|
0.13
|
0.14
|
| Income Tax Expense |
$67.82 M
|
$100.91 M
|
$130.38 M
|
$81.87 M
|
$81.81 M
|
$50.02 M
|
$54.46 M
|
$171.37 M
|
$66.84 M
|
$43.39 M
|
| Net Income |
$10.30 M
|
$474.62 M
|
$486.23 M
|
$390.98 M
|
$364.30 M
|
$252.02 M
|
$226.37 M
|
$123.36 M
|
$154.77 M
|
$149.31 M
|
| Net Income Ratio |
0
|
0.11
|
0.12
|
0.11
|
0.12
|
0.1
|
0.1
|
0.07
|
0.09
|
0.11
|
| EPS |
0.2 |
9.27 |
9.57 |
7.77 |
7.35 |
5.17 |
4.72 |
2.6 |
3.29 |
3.21 |
| EPS Diluted |
0.2 |
9.22 |
9.48 |
7.6 |
7.2 |
5.07 |
4.62 |
2.54 |
3.23 |
3.13 |
| Weighted Average Shares Out |
$51.38 M
|
$51.23 M
|
$50.81 M
|
$50.29 M
|
$49.55 M
|
$48.73 M
|
$47.95 M
|
$47.48 M
|
$47.01 M
|
$46.50 M
|
| Weighted Average Shares Out Diluted |
$51.63 M
|
$51.45 M
|
$51.30 M
|
$51.43 M
|
$50.61 M
|
$49.69 M
|
$49.02 M
|
$48.56 M
|
$47.96 M
|
$47.63 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
